isradipine has been researched along with Hyperlipemia in 1 studies
Isradipine: A potent antagonist of CALCIUM CHANNELS that is highly selective for VASCULAR SMOOTH MUSCLE. It is effective in the treatment of chronic stable angina pectoris, hypertension, and congestive cardiac failure.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The hypothesis that plasma lipids may modulate the antihypertensive effect of the calcium antagonist isradipine was tested in 85 patients who had essential hypertension." | 5.07 | Antihypertensive effect of the calcium antagonist isradipine and lipid profile. ( Farsang, C; Kapocsi, J; Kiss, I; Maklári, E; Török, E, 1993) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Farsang, C | 1 |
| Kiss, I | 1 |
| Kapocsi, J | 1 |
| Török, E | 1 |
| Maklári, E | 1 |
1 trial available for isradipine and Hyperlipemia
| Article | Year |
|---|---|
Antihypertensive effect of the calcium antagonist isradipine and lipid profile.
Topics: Adult; Aged; Blood Pressure; Cholesterol; Humans; Hyperlipidemias; Hypertension; Isradipine; Linear | 1993 |